Physician profile
Jacqueline Abraham
NPI 1194292219
$2,696.01
in general payments reported to CMS, 2019-2025
15 companies · $366 in 2025
The $366 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $126 · 2022: $111 · 2023: $460 · 2024: $1,632 · 2025: $366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,329 · Consulting Fee: $1,045 · Education: $83.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,329.49 |
| Consulting Fee | $1,045.00 |
| Education | $83.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $1,213.94 | 2024-2025 | Monjuvi |
| Astellas Pharma US INC | $663.31 | 2021-2025 | Cresemba, Xospata |
| Janssen Scientific Affairs, LLC | $231.66 | 2022-2025 | Carvykti, Talvey, Tecvayli |
| Legend Biotech USA INC. | $176.62 | 2023-2025 | Carvykti |
| Rigel Pharmaceuticals, INC. | $116.62 | 2023 | Rezlidhia, Tavalisse |
| Karyopharm Therapeutics INC. | $74.83 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $43.90 | 2021-2025 | Zerbaxa, Prevymis |
| Boston Scientific Corporation | $41.72 | 2024 | Bodyguardian |
| Adaptive Biotechnologies Corporation | $23.12 | 2022 | |
| Morphosys, US INC. | $22.46 | 2023 | Monjuvi |
| Takeda Pharmaceuticals U.S.A., INC. | $20.49 | 2024 | Livtencity |
| Amgen INC. | $19.41 | 2021 | |
| Janssen Biotech, INC. | $19.32 | 2024 | Talvey, Tecvayli |
| Medtronic, INC. | $14.56 | 2025 | Midas Rex |
| Celgene Corporation | $14.05 | 2023 | Onureg |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Abraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.